Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 11 |
GO:0110165 | cellular anatomical entity | 1 | 11 |
GO:0005789 | endoplasmic reticulum membrane | 4 | 1 |
GO:0005886 | plasma membrane | 3 | 1 |
GO:0031090 | organelle membrane | 3 | 1 |
GO:0044232 | organelle membrane contact site | 2 | 1 |
GO:0140268 | endoplasmic reticulum-plasma membrane contact site | 3 | 1 |
Related structures:
AlphaFold database: A4H910
Term | Name | Level | Count |
---|---|---|---|
GO:0006810 | transport | 3 | 1 |
GO:0006869 | lipid transport | 5 | 1 |
GO:0009987 | cellular process | 1 | 1 |
GO:0015850 | organic hydroxy compound transport | 5 | 1 |
GO:0015918 | sterol transport | 6 | 1 |
GO:0032365 | intracellular lipid transport | 4 | 1 |
GO:0032366 | intracellular sterol transport | 5 | 1 |
GO:0046907 | intracellular transport | 3 | 1 |
GO:0051179 | localization | 1 | 1 |
GO:0051234 | establishment of localization | 2 | 1 |
GO:0051641 | cellular localization | 2 | 1 |
GO:0051649 | establishment of localization in cell | 3 | 1 |
GO:0071702 | organic substance transport | 4 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005215 | transporter activity | 1 | 1 |
GO:0005319 | lipid transporter activity | 2 | 1 |
GO:0005488 | binding | 1 | 1 |
GO:0005496 | steroid binding | 3 | 1 |
GO:0008289 | lipid binding | 2 | 1 |
GO:0015248 | sterol transporter activity | 3 | 1 |
GO:0032934 | sterol binding | 4 | 1 |
GO:0097159 | organic cyclic compound binding | 2 | 1 |
GO:0120013 | lipid transfer activity | 3 | 1 |
GO:0120015 | sterol transfer activity | 4 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 303 | 307 | PF00656 | 0.442 |
CLV_MEL_PAP_1 | 295 | 301 | PF00089 | 0.520 |
CLV_NRD_NRD_1 | 356 | 358 | PF00675 | 0.498 |
CLV_NRD_NRD_1 | 78 | 80 | PF00675 | 0.238 |
CLV_PCSK_KEX2_1 | 356 | 358 | PF00082 | 0.432 |
CLV_PCSK_SKI1_1 | 102 | 106 | PF00082 | 0.255 |
CLV_PCSK_SKI1_1 | 125 | 129 | PF00082 | 0.262 |
CLV_PCSK_SKI1_1 | 324 | 328 | PF00082 | 0.474 |
CLV_PCSK_SKI1_1 | 55 | 59 | PF00082 | 0.272 |
DEG_APCC_DBOX_1 | 124 | 132 | PF00400 | 0.492 |
DEG_APCC_DBOX_1 | 323 | 331 | PF00400 | 0.202 |
DEG_Nend_UBRbox_2 | 1 | 3 | PF02207 | 0.498 |
DOC_CKS1_1 | 45 | 50 | PF01111 | 0.606 |
DOC_MAPK_DCC_7 | 43 | 51 | PF00069 | 0.502 |
DOC_MAPK_gen_1 | 207 | 214 | PF00069 | 0.441 |
DOC_MAPK_MEF2A_6 | 130 | 139 | PF00069 | 0.498 |
DOC_MAPK_MEF2A_6 | 324 | 332 | PF00069 | 0.202 |
DOC_USP7_MATH_1 | 17 | 21 | PF00917 | 0.629 |
DOC_USP7_MATH_1 | 218 | 222 | PF00917 | 0.610 |
DOC_USP7_MATH_1 | 240 | 244 | PF00917 | 0.668 |
DOC_USP7_MATH_1 | 286 | 290 | PF00917 | 0.315 |
DOC_WW_Pin1_4 | 131 | 136 | PF00397 | 0.546 |
DOC_WW_Pin1_4 | 44 | 49 | PF00397 | 0.617 |
LIG_14-3-3_CanoR_1 | 102 | 110 | PF00244 | 0.450 |
LIG_14-3-3_CanoR_1 | 192 | 202 | PF00244 | 0.504 |
LIG_14-3-3_CanoR_1 | 287 | 291 | PF00244 | 0.455 |
LIG_14-3-3_CterR_2 | 356 | 361 | PF00244 | 0.558 |
LIG_Actin_WH2_2 | 170 | 187 | PF00022 | 0.405 |
LIG_Actin_WH2_2 | 263 | 279 | PF00022 | 0.467 |
LIG_AP2alpha_1 | 150 | 154 | PF02296 | 0.480 |
LIG_CaM_NSCaTE_8 | 316 | 323 | PF13499 | 0.411 |
LIG_EH1_1 | 153 | 161 | PF00400 | 0.424 |
LIG_eIF4E_1 | 123 | 129 | PF01652 | 0.492 |
LIG_FHA_1 | 105 | 111 | PF00498 | 0.451 |
LIG_FHA_1 | 132 | 138 | PF00498 | 0.449 |
LIG_FHA_1 | 172 | 178 | PF00498 | 0.441 |
LIG_FHA_1 | 262 | 268 | PF00498 | 0.441 |
LIG_FHA_1 | 280 | 286 | PF00498 | 0.304 |
LIG_FHA_1 | 67 | 73 | PF00498 | 0.540 |
LIG_FHA_2 | 194 | 200 | PF00498 | 0.457 |
LIG_FHA_2 | 4 | 10 | PF00498 | 0.576 |
LIG_IRF3_LxIS_1 | 330 | 336 | PF10401 | 0.420 |
LIG_LIR_Gen_1 | 22 | 31 | PF02991 | 0.545 |
LIG_LIR_Gen_1 | 278 | 288 | PF02991 | 0.504 |
LIG_LIR_Gen_1 | 36 | 46 | PF02991 | 0.510 |
LIG_LIR_Nem_3 | 122 | 126 | PF02991 | 0.477 |
LIG_LIR_Nem_3 | 22 | 27 | PF02991 | 0.562 |
LIG_LIR_Nem_3 | 278 | 283 | PF02991 | 0.444 |
LIG_LIR_Nem_3 | 315 | 319 | PF02991 | 0.482 |
LIG_LIR_Nem_3 | 336 | 341 | PF02991 | 0.483 |
LIG_LIR_Nem_3 | 36 | 41 | PF02991 | 0.504 |
LIG_MYND_1 | 247 | 251 | PF01753 | 0.671 |
LIG_Pex14_1 | 280 | 284 | PF04695 | 0.287 |
LIG_Pex14_2 | 150 | 154 | PF04695 | 0.480 |
LIG_Pex14_2 | 61 | 65 | PF04695 | 0.462 |
LIG_REV1ctd_RIR_1 | 281 | 291 | PF16727 | 0.297 |
LIG_SH2_SRC | 118 | 121 | PF00017 | 0.519 |
LIG_SH2_STAT5 | 120 | 123 | PF00017 | 0.536 |
LIG_SH2_STAT5 | 180 | 183 | PF00017 | 0.531 |
LIG_SH2_STAT5 | 331 | 334 | PF00017 | 0.451 |
LIG_SH3_3 | 42 | 48 | PF00018 | 0.589 |
MOD_CDK_SPxK_1 | 44 | 50 | PF00069 | 0.593 |
MOD_CK1_1 | 167 | 173 | PF00069 | 0.530 |
MOD_CK1_1 | 33 | 39 | PF00069 | 0.521 |
MOD_CK2_1 | 22 | 28 | PF00069 | 0.550 |
MOD_CK2_1 | 3 | 9 | PF00069 | 0.650 |
MOD_CK2_1 | 36 | 42 | PF00069 | 0.476 |
MOD_CMANNOS | 86 | 89 | PF00535 | 0.262 |
MOD_Cter_Amidation | 354 | 357 | PF01082 | 0.421 |
MOD_GlcNHglycan | 131 | 134 | PF01048 | 0.336 |
MOD_GlcNHglycan | 166 | 169 | PF01048 | 0.340 |
MOD_GlcNHglycan | 221 | 224 | PF01048 | 0.476 |
MOD_GlcNHglycan | 277 | 280 | PF01048 | 0.564 |
MOD_GlcNHglycan | 32 | 35 | PF01048 | 0.389 |
MOD_GlcNHglycan | 320 | 323 | PF01048 | 0.679 |
MOD_GSK3_1 | 129 | 136 | PF00069 | 0.546 |
MOD_GSK3_1 | 160 | 167 | PF00069 | 0.531 |
MOD_GSK3_1 | 193 | 200 | PF00069 | 0.524 |
MOD_GSK3_1 | 22 | 29 | PF00069 | 0.542 |
MOD_GSK3_1 | 241 | 248 | PF00069 | 0.596 |
MOD_GSK3_1 | 275 | 282 | PF00069 | 0.509 |
MOD_GSK3_1 | 85 | 92 | PF00069 | 0.455 |
MOD_NEK2_1 | 104 | 109 | PF00069 | 0.462 |
MOD_NEK2_1 | 129 | 134 | PF00069 | 0.556 |
MOD_NEK2_1 | 255 | 260 | PF00069 | 0.691 |
MOD_NEK2_1 | 3 | 8 | PF00069 | 0.588 |
MOD_NEK2_1 | 333 | 338 | PF00069 | 0.354 |
MOD_NEK2_2 | 171 | 176 | PF00069 | 0.494 |
MOD_NEK2_2 | 279 | 284 | PF00069 | 0.331 |
MOD_PIKK_1 | 140 | 146 | PF00454 | 0.505 |
MOD_PIKK_1 | 160 | 166 | PF00454 | 0.489 |
MOD_PIKK_1 | 22 | 28 | PF00454 | 0.623 |
MOD_PKA_1 | 79 | 85 | PF00069 | 0.448 |
MOD_PKA_2 | 286 | 292 | PF00069 | 0.486 |
MOD_PKA_2 | 355 | 361 | PF00069 | 0.617 |
MOD_Plk_1 | 171 | 177 | PF00069 | 0.511 |
MOD_Plk_1 | 240 | 246 | PF00069 | 0.661 |
MOD_Plk_1 | 36 | 42 | PF00069 | 0.533 |
MOD_Plk_1 | 66 | 72 | PF00069 | 0.381 |
MOD_Plk_4 | 105 | 111 | PF00069 | 0.450 |
MOD_Plk_4 | 279 | 285 | PF00069 | 0.390 |
MOD_ProDKin_1 | 131 | 137 | PF00069 | 0.546 |
MOD_ProDKin_1 | 44 | 50 | PF00069 | 0.621 |
MOD_SUMO_rev_2 | 73 | 82 | PF00179 | 0.505 |
MOD_SUMO_rev_2 | 8 | 16 | PF00179 | 0.575 |
TRG_ENDOCYTIC_2 | 118 | 121 | PF00928 | 0.512 |
TRG_ENDOCYTIC_2 | 126 | 129 | PF00928 | 0.453 |
TRG_ENDOCYTIC_2 | 180 | 183 | PF00928 | 0.515 |
TRG_ENDOCYTIC_2 | 206 | 209 | PF00928 | 0.435 |
TRG_ENDOCYTIC_2 | 331 | 334 | PF00928 | 0.448 |
TRG_NES_CRM1_1 | 303 | 315 | PF08389 | 0.378 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0S4JTD3 | Bodo saltans | 27% | 84% |
A0A1X0NTC3 | Trypanosomatidae | 41% | 100% |
A0A3Q8IAW1 | Leishmania donovani | 80% | 100% |
A0A3R7N4K3 | Trypanosoma rangeli | 46% | 100% |
A0A3R7RDH3 | Trypanosoma rangeli | 40% | 100% |
A0A422NZS9 | Trypanosoma rangeli | 27% | 95% |
A4HXE2 | Leishmania infantum | 80% | 100% |
E9AR37 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 80% | 100% |
Q4QEC6 | Leishmania major | 79% | 100% |
V5BE10 | Trypanosoma cruzi | 46% | 100% |